COVID-19 vaccine effectiveness studies in Nigeria: Quo vadis?

Autor:	Oluwatosin Wuraola Akande, Ehimario Uche Igumbor, Kelly Osezele Elimian, Cornelius Ehizokhai Ohonsi, Lilian Nwozor, Okanke Oden, Emmanuel Nsa Ekpenyong, Nnaemeka Ndodo, Ifeanyi F Ike, Magdalene Egede, William Nwachukwu, Amedu M Onoja, Jenson Gawain Fofah, Reuben Ishiaku Azi, Chinwe L Ochu, Ifedayo M Adetifa
Rok vydání:	2022
Předmět:	COVID-19 Vaccines Research Health Policy Public Health Environmental and Occupational Health COVID-19 Humans Nigeria Vaccine Efficacy
Zdroj:	Journal of Global Health. 12
ISSN:	2047-2986 2047-2978
Popis:	The “lickety-split” development of COVID-19 vaccines 326 days from when the SARS-COV-2 virus was first sequenced is indeed one of the public health successes of the 21st century. Particularly because an 18-month target was initially considered reasonable, and having achieved this success, a “moonshot” goal to ensure that a vaccine is available within 100 days after the next pandemic pathogen is recognized has been set [1].
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5d42b48bbfc343a3807d7d63bbb7490 https://doi.org/10.7189/jogh.12.03055 Zobrazit plný text záznamu